These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19047976)

  • 1. Helicobacter pylori eradication: metronidazole or tinidazole? Data from Turin, Italy.
    Berrutti M; Pellicano R; Astegiano M; Smedile A; Saracco G; Morgando A; De Angelis C; Repici A; Fagoonee S; Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2008 Dec; 54(4):355-8. PubMed ID: 19047976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
    Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
    Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
    Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
    Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity.
    Bhatia V; Ahuja V; Das B; Bal C; Sharma MP
    J Gastroenterol Hepatol; 2004 Jun; 19(6):619-25. PubMed ID: 15151614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice.
    Sánchez-Delgado J; Calvet X; Bujanda L; Gisbert JP; Titó L; Castro M
    Am J Gastroenterol; 2008 Sep; 103(9):2220-3. PubMed ID: 18564109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of the metronidazole-containing regimen for eradication of Helicobacter pylori infection in northern Japan.
    Fukuda S; Shimoyama T; Tanaka M; Nakasato F; Fukushi M; Munakata A
    Jpn J Infect Dis; 2006 Dec; 59(6):367-9. PubMed ID: 17186954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
    Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
    J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
    Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
    Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreasing eradicaton rate of Helicobacter pylori infection with metronidazole-based triple therapy. A randomised study.
    Pellicano R; Palmas F; Ponzetto A; Astegiano M; Smedile A; Morgando A; Bonardi R; Berrutti M; Touscoz GA; Rizzetto M
    Minerva Gastroenterol Dietol; 2002 Sep; 48(3):265-70. PubMed ID: 16491050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of two triple-therapy regimens with metronidazole or clarithromycin for the eradication of H. pylori infection in Vietnamese children: a randomized, double-blind clinical trial.
    Nguyen TV; Bengtsson C; Nguyen GK; Hoang TT; Phung DC; Sörberg M; Granström M
    Helicobacter; 2008 Dec; 13(6):550-6. PubMed ID: 19166421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment for Helicobacter pylori: current criteria].
    Vaira D; Zullo A; Ricci C; Gigliotti F; Morini S
    Recenti Prog Med; 2007 Nov; 98(11):574-82; quiz 602. PubMed ID: 18044409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.
    Navarro-Jarabo JM; Fernández N; Sousa FL; Cabrera E; Castro M; Ramírez LM; Rivera R; Ubiña E; Vera F; Méndez I; Rivas-Ruiz F; Moreno JL; Perea-Milla E
    BMC Gastroenterol; 2007 Jul; 7():31. PubMed ID: 17651479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens.
    Filipec Kanizaj T; Katicic M; Skurla B; Ticak M; Plecko V; Kalenic S
    Helicobacter; 2009 Feb; 14(1):29-35. PubMed ID: 19191893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful platelet recovery after the second eradication of Helicobacter pylori with metronidazole in two patients with chronic idiopathic thrombocytopenic purpura].
    Takahashi T; Hatao K; Yamada K
    Rinsho Ketsueki; 2006 May; 47(5):392-5. PubMed ID: 16784096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
    Romano M; Iovene MR; Russo MI; Rocco A; Salerno R; Cozzolino D; Pilloni AP; Tufano MA; Vaira D; Nardone G
    J Clin Pathol; 2008 Oct; 61(10):1112-5. PubMed ID: 18755715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country.
    Fischbach LA; Bravo LE; Zarama GR; Bravo JC; Ojha RP; Priest EL; Collazos T; Casabon AL; Guerrero LZ; Singh KP; Correa P
    Helicobacter; 2009 Apr; 14(2):100-8. PubMed ID: 19298337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variables influencing outcome of Helicobacter pylori eradication therapy in South China.
    Cai W; Zhou L; Ren W; Deng L; Yu M
    Helicobacter; 2009 Oct; 14(5):91-6. PubMed ID: 19751433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new eradication resistance index as a predictor of metronidazole-containing second-line treatment of Helicobacter pylori.
    Nishizawa T; Suzuki H; Masaoka T; Iwasaki E; Hibi T
    Digestion; 2007; 76(3-4):215-20. PubMed ID: 18174683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High efficacy of bismuth subcitrate for Helicobacter pylori eradication in pangastritis.
    Severi C; Abdullahi M; Tari R; Vannella L; Marcheggiano A; Capoccia D; Leonetti F; Osborn J; Annibale B
    Dig Liver Dis; 2009 Aug; 41(8):555-8. PubMed ID: 19179127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.